Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddys Laboratories reports 65% rise in Q3 consolidated net profit

Date: 01-02-2019

Dr. Reddys Laboratories has reported results for third quarter ended December 31, 2018.

The company has reported a rise of 34.52% in its net profit at Rs 399.40 crore for the quarter under review as compared to Rs 296.90 crore for the same quarter in the previous year. Total income of the company increased by 9.87% at Rs 2,824.50 crore for Q3FY19 as compared Rs 2,570.70 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 65.28% in its net profit at Rs 500.30 crore for the quarter under review as compared to Rs 302.70 crore for the same quarter in the previous year. Total income of the company increased by 2.32% at Rs 3,966.90 crore for Q3FY19 as compared Rs 3,877.10 crore for the corresponding quarter previous year.